Prof Robert Cooper

Journal article

Farrant JP, Schmitt M, Reid AB, Garratt CJ, Newman WG, Malhotra A, Beynon R, Mahmod M, Raman B, Cooper RM, Dawson D, Green T, Prasad SK, Singh A, Dodd S, Watkins H, Neubauer S, Miller CA. 2024. Considerations for drug trials in hypertrophic cardiomyopathy ESC Heart Failure, DOI Publisher Url Public Url

Crean AM, Adler A, Arbour L, Chan J, Christian S, Cooper RM, Garceau P, Giraldeau G, Heydari B, Laksman Z, Mital S, Ong K, Overgaard C, Ruel M, Seifer CM, Ward MR, Tadros R. 2024. Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of the Patient with Hypertrophic Cardiomyopathy Canadian Journal of Cardiology, 40 :1503-1523 DOI Author Url Publisher Url Public Url

Ding WY, Meah MN, Stables R, Cooper RM. 2024. Interventions in Hypertrophic Obstructive Cardiomyopathy Canadian Journal of Cardiology, 40 :833-842 DOI Author Url Publisher Url

Meah MN, Ding WY, Cooper RM, Stables RH. 2024. Invasive Management of Hypertrophic Cardiomyopathy With Clinically Important Obstruction: Catheter Intervention Is Superior Canadian Journal of Cardiology, 40 :851-859 DOI Author Url Publisher Url

Oxborough D, McDerment D, George KP, Johnson C, Morrison B, Parry-Williams G, Papatheodorou E, Sharma S, Cooper R. 2024. Allometric scaling for left ventricular mass and geometry in male and female athletes of mixed and endurance sports Echo Research and Practice, 11 DOI Author Url Publisher Url Public Url

Place F, Carpenter H, Morrison BN, Chester N, Cooper R, Stansfield BN, George KP, Oxborough D. 2023. The impact of image and performance enhancing drugs on atrial structure and function in resistance trained individuals Echo Research and Practice, 10 :1-12 DOI Author Url Publisher Url Public Url

Veselka J, Liebregts M, Cooper R, Faber L, Januska J, Tesarkova KH, Hansen PR, Seggewiss H, Hansvenclova E, Bonaventura J, Vejtasova V, ten Berg J, Stables RH, Jensovsky M. 2023. Outcomes of Alcohol Septal Ablation in Patients With Severe Left Ventricular Outflow Tract Obstruction: A Propensity Score Matching Analysis Canadian Journal of Cardiology, 39 :1622-1629 DOI Author Url Publisher Url

Flanagan H, Cooper R, George KP, Augustine DX, Malhotra A, Paton MF, Robinson S, Oxborough D. 2023. The athlete's heart: insights from echocardiography. Echo Research & Practice, 10 DOI Author Url Publisher Url Public Url

McGregor-Cheers R, Forsythe L, Cooper R, Johnson C, Sculthorpe N, Papadakis M, Mill N, Daniels M, Kleinnibbelink G, George K, Oxborough D. 2023. Comparison of echocardiographic methods for calculating left ventricular mass in elite rugby football league athletes and the impact on chamber geometry Frontiers in Sports and Active Living, 5 :1270444 DOI Author Url Publisher Url Public Url

Moody WE, Turvey-Haigh L, Knight D, Coats CJ, Cooper RM, Schofield R, Robinson S, Harkness A, Oxborough DL, Gillmore JD, Whelan C, Augustine DX, Fontana M, Steeds RP. 2023. British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis. Echo Research and Practice, 10 :13 DOI Author Url Publisher Url Public Url

Johnson C, Sculthorpe N, George K, Stout M, Procter W, Cooper RM, Oxborough D. 2023. Concentric and Eccentric Remodelling of the Left Ventricle and Its Association to Function in the Male Athletes Heart: An Exploratory Study Journal of Cardiovascular Development and Disease, 10 :269 DOI Author Url Publisher Url Public Url

Lampert R, Ackerman MJ, Marino BS, Burg M, Ainsworth B, Salberg L, Tome Esteban MT, Ho CY, Abraham R, Balaji S, Barth C, Berul CI, Bos M, Cannom D, Choudhury L, Concannon M, Cooper R, Czosek RJ, Dubin AM, Dziura J, Eidem B, Emery MS, Estes NAM, Etheridge SP, Geske JB, Gray B, Hall K, Harmon KG, James CA, Lal AK, Law IH, Li F, Link MS, McKenna WJ, Molossi S, Olshansky B, Ommen SR, Saarel EV, Saberi S, Simone L, Tomaselli G, Ware JS, Zipes DP, Day SM. 2023. Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy JAMA Cardiology, 8 :595-605 DOI Author Url Publisher Url

Farrant J, Dodd S, Vaughan C, Reid A, Schmitt M, Garratt C, Akhtar M, Mahmod M, Neubauer S, Cooper RM, Prasad SK, Singh A, Valkovič L, Raman B, Ashkir Z, Clayton D, Baroja O, Duran B, Spowart C, Bedson E, Naish JH, Harrington C, Miller CA, TEMPEST investigators . 2023. Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy. Heart (British Cardiac Society), DOI Author Url Publisher Url Public Url

Bhatia RT, Malhotra A, MacLachlan H, Gati S, Marwaha S, Chatrath N, Fyyaz S, Aleixo H, Al-Turaihi S, Babu A, Basu J, Catterson P, Cooper R, Daems JJN, Dhutia H, Ferrari F, van Hattum JC, Iqbal Z, Kasiakogias A, Kenny A, Khanbhai T, Khoury S, Miles C, Oxborough D, Quazi K, Rakhit D, Sharma A, Varnava A, Tome Esteban MT, Finocchiaro G, Stein R, Jorstad HT, Papadakis M, Sharma S. 2023. Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players. Heart, DOI Author Url Publisher Url Public Url

Veselka J, Liebregts M, Cooper R, Faber L, Januska J, Kashtanov M, Tesarkova KH, Hansen PR, Seggewiss H, Shloydo E, Popov K, Hansvenclova E, Bonaventura J, Berg JT, Stables RH, Polakova E. 2022. Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation JACC: Cardiovascular Interventions, 15 :1910-1917 DOI Author Url Publisher Url

Veselka J, Liebregts M, Cooper R, Faber L, Januska J, Kashtanov M, Tesarkova KH, Hansen PR, Seggewiss H, Shloydo E, Popov K, Hansvenclova E, Polakova E, ten Berg J, Stables RH, Jarkovsky J, Bonaventura J. 2022. Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score American Journal of Cardiology, 184 :120-126 DOI Author Url Publisher Url

Gillmore JD, Reilly MM, Coats CJ, Cooper R, Cox H, Coyne MRE, Green AJ, McGowan R, Moody WE, Hawkins PN. 2022. Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK Advances in Therapy, 39 :2292-2301 DOI Author Url Publisher Url Public Url

FitzMaurice TS, Cooper RM, Snowdon R, Arzanauskaite M, Nazareth D, Walshaw M. 2022. Cardiac sarcoidosis in an adult person with cystic fibrosis: a case report Sarcoidosis Vasculitis and Diffuse Lung Diseases, 39 DOI Author Url

Raphael CE, Mitchell F, Kanaganayagam GS, Liew AC, Di Pietro E, Vieira MS, Kanapeckaite L, Newsome S, Gregson J, Owen R, Hsu LY, Vassiliou V, Cooper R, Mrcp AA, Ismail TF, Wong B, Sun K, Gatehouse P, Firmin D, Cook S, Frenneaux M, Arai A, O’Hanlon R, Pennell DJ, Prasad SK. 2021. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation Journal of Cardiovascular Magnetic Resonance, 23 DOI Author Url Publisher Url Public Url

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Bonaventura J, Polakova E, Hansvenclova E, Bundgaard H, ten Berg J, Stables RH, Jarkovsky J, Jensen MK. 2021. Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy International Journal of Cardiology, 333 :127-132 DOI Author Url Publisher Url Public Url

Raphael CE, Liew AC, Mitchell F, Kanaganayagam GS, Di Pietro E, Newsome S, Owen R, Gregson J, Cooper R, Amin FR, Gatehouse P, Vassiliou V, Ernst S, O'Hanlon R, Frenneaux M, Pennell DJ, Prasad SK. 2020. Predictors and Mechanisms of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy American Journal of Cardiology, 136 :140-148 DOI Author Url Publisher Url

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Krejci J, Dabrowski M, Hansen PR, Seggewiss H, Horstkotte D, Hansvenclova E, Bundgaard H, ten Berg J, Jensen MK. 2020. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Insight from the Euro-ASA registry Archives of Medical Science, 16 :1239-1242 DOI Author Url Publisher Url

Veselka J, Jensen M, Liebregts M, Cooper RM, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Hansvenclova E, Bundgaard H, Ten Berg J, Hilton Stables R, Faber L. 2020. Alcohol septal ablation in patients with severe septal hypertrophy Heart, 106 :462-466 DOI Author Url Publisher Url

Jensen MK, Faber L, Liebregts M, Januska J, Krejci J, Bartel T, Cooper RM, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Berg JT, Bundgaard H, Veselka J. 2019. Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: Insights from the Euro-ASA registry European Heart Journal - Quality of Care and Clinical Outcomes, 5 :252-258 DOI Author Url Publisher Url

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Hansvenclova E, Bundgaard H, Ten Berg J, Stables RH, Jensen MK. 2019. Short- And long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: A propensity score matching analysis European Heart Journal, 40 :1681-1687 DOI Author Url Publisher Url

Denham NC, Pearman CM, Ding WY, Waktare J, Gupta D, Snowdon R, Hall M, Cooper R, Modi S, Todd D, Mahida S. 2019. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome Journal of Cardiovascular Electrophysiology, 30 :118-127 DOI Author Url Publisher Url

Khanna V, Shahzad A, Thayalasamy K, Kemp I, Mars C, Cooper R, Roome C, Wilson K, Harris S, Stables R, Curzen N. 2018. Comparison of the antiplatelet and antithrombotic effects of bivalirudin versus unfractionated heparin: A platelet substudy of the HEAT PPCI trial Thrombosis Research, 172 :36-43 DOI Author Url Publisher Url

Naraen A, McKay V, Shaw M, Modi S, Fairbairn T, Somauroo J, Todd D, Cooper R. 2018. Clinical predictors of informative genetic testing in hypertrophic cardiomyopathy. European Journal of Preventative Cardiology, DOI Author Url Publisher Url Public Url

Ding WY, Cooper R, Todd D, Gupta D, Hall M, Rao A, Wright J, Snowdon R, Waktare J, Modi S. 2018. Natural progression of QRS duration in ICD-only patients Journal of Interventional Cardiac Electrophysiology, 53 :47-51 DOI Author Url Publisher Url

Popple E, George KP, Somauroo J, Sharma S, Utomi V, Lord R, Cooper R, Malhotra A, Forster J, Oxborough D. 2018. Right Ventricular Structure and Function in Senior and Academy Elite Footballers. Scandinavian Journal of Medicine and Science in Sports, DOI Author Url Publisher Url Public Url

Shahzad A, Khanna V, Kemp I, Shaw M, Mars C, Cooper R, Wilson K, Curzen N, Stables RH. 2018. Comparison of the effects of P2Y12 receptor antagonists on platelet function in patients undergoing primary PCI: A substudy of the HEAT-PPCI trial EuroIntervention, 13 :1931-1938 DOI Author Url Publisher Url

Veselka J, Faber L, Jensen MK, Cooper R, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, ten Berg J, Liebregts M. 2018. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Canadian Journal of Cardiology, 34 :16-22 DOI Author Url Publisher Url

Cooper RM, Stables RH. 2018. Non-surgical septal reduction therapy in hypertrophic cardiomyopathy Heart, 104 :73-83 DOI Author Url Publisher Url

Liew AC, Vassiliou VS, Cooper R, Raphael CE. 2017. Hypertrophic cardiomyopathy—past, present and future Journal of Clinical Medicine, 6 DOI Author Url Publisher Url

Cooper RM, Raphael CE, Liebregts M, Anavekar NS, Veselka J. 2017. New Developments in Hypertrophic Cardiomyopathy Canadian Journal of Cardiology, 33 :1254-1265 DOI Author Url Publisher Url

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Berg JT, Stables RH, Jensen MK. 2017. Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A long-term follow-up study based on the Euro-alcohol septal ablation registry Journal of the American Heart Association, 6 DOI Author Url Publisher Url

Cooper RM, Binukrishnan SR, Shahzad A, Hasleton J, Sigwart U, Stables RH. 2017. Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy EuroIntervention, 12 :e2194-e2203 DOI Author Url Publisher Url

Raphael CE, Keegan J, Parker KH, Simpson R, Collinson J, Vassiliou V, Wage R, Drivas P, Strain S, Cooper R, de Silva R, Stables RH, Di Mario C, Frenneaux M, Pennell DJ, Davies JE, Hughes AD, Firmin D, Prasad SK. 2016. Feasibility of cardiovascular magnetic resonance derived coronary wave intensity analysis Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 18 :93 DOI Author Url Publisher Url

Raphael CE, Keegan J, Parker KH, Simpson R, Collinson J, Vassiliou V, Wage R, Drivas P, Strain S, Cooper R, De Silva R, Stables RH, Di Mario C, Frenneaux M, Pennell DJ, Davies JE, Hughes AD, Firmin D, Prasad SK. 2016. Feasibility of cardiovascular magnetic resonance derived coronary wave intensity analysis Journal of Cardiovascular Magnetic Resonance, 18 :1-12 DOI

Ding WY, Cooper RM, Hasleton J, McKay V, Modi S. 2016. Ventricular Hinge Point Fibrosis as a Pathological Marker of Hypertrophic Cardiomyopathy in the Absence of Significant Left Ventricular Hypertrophy? Canadian Journal of Cardiology, 32 :1577.e13-1577.e14 DOI Author Url Publisher Url

Poon SS, Cooper RM, Gupta D. 2016. Endocardial radiofrequency septal ablation — A new option for non-surgical septal reduction in patients with hypertrophic obstructive cardiomyopathy (HOCM)?: A systematic review of clinical studies International Journal of Cardiology, 222 :772-774 DOI Author Url Publisher Url

Raphael CE, Cooper R, Parker KH, Collinson J, Vassiliou V, Pennell DJ, de Silva R, Hsu LY, Greve AM, Nijjer S, Broyd C, Ali A, Keegan J, Francis DP, Davies JE, Hughes AD, Arai A, Frenneaux M, Stables RH, Di Mario C, Prasad SK. 2016. Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance Journal of the American College of Cardiology, 68 :1651-1660 DOI Author Url Publisher Url

Shahzad A, Mars C, Kemp I, Cooper R, Arnold P, Roome C, Wilson K, McLenachan J, Gray H, Morris J, Stables RH. 2016. Describing Activity in Primary Percutaneous Coronary Intervention: An Exploration of Denominators. from the HEAT Trial - A Systematic Evaluation of PPCI Activations in Liverpool, Explaining Denominators (HEAT-SEALED) Journal of Invasive Cardiology, 28 :247-252 Author Url

Cooper RM, Shahzad A, Hasleton J, Digiovanni J, Hall MC, Todd DM, Modi S, Stables RH. 2015. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: A novel use of CARTOSound® technology to guide ablation Europace, 18 :113-120 DOI Author Url Publisher Url

Cooper RM, Shahzad A, McShane J, Stables RH. 2015. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Safe and apparently efficacious but does reporting of aggregate outcomes hide less-favorable results, experienced by a substantial proportion of patients? Journal of Invasive Cardiology, 27 :301-308 Author Url

Cooper RM, Shahzad A, Stables RH. 2015. Intervention in HCM: Patient selection, procedural approach and emerging techniques in alcohol septal ablation Echo Research and Practice, 2 :R25-R35 DOI Author Url Publisher Url

Cooper RM, Shahzad A, Newton J, Vejlstrup N, Axelsson A, Sharma V, Ormerod O, Stables RH. 2015. Intra-cardiac echocardiography in alcohol septal ablation: A prospective comparative study against trans-thoracic echocardiography Echo Research and Practice, 2 :9-17 DOI Author Url Publisher Url

Cooper RM, Stables RH. 2015. Can RAS inhibitors affect the course of hypertrophic cardiomyopathy? The Lancet Diabetes and Endocrinology, 3 :95-96 DOI Author Url Publisher Url

Shahzad A, Kemp I, Mars C, Wilson K, Roome C, Cooper R, Andron M, Appleby C, Fisher M, Khand A, Kunadian B, Mills JD, Morris JL, Morrison WL, Munir S, Palmer ND, Perry RA, Ramsdale DR, Velavan P, Stables RH. 2014. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial LANCET, 384 :1849-1858 DOI Author Url Publisher Url

Murray SW, Cooper RM, Appleby C, McCann C, Binukrishnan S, Radu MD, Stables RH. 2014. Double jeopardy: Multi-modality imaging of monozygotic "twin cap" atherosclerosis Atherosclerosis, 237 :264-267 DOI Author Url Publisher Url

Shahzad A, Cooper RM, Stables RH. 2013. Antithrombotic therapy in PCI: Why not heparin? EuroIntervention, 9 :423-426 DOI Author Url Publisher Url

Cooper RM, Shahzad A, Stables RH. 2013. Current status of nonsurgical septal reduction therapy in hypertrophic obstructive cardiomyopathy Interventional Cardiology (London), 5 :427-439 DOI Publisher Url

Modi S, Cooper R, Obeyesekere M, Gula L. 2013. And it just keeps on pacing! PACE - Pacing and Clinical Electrophysiology, 36 :778-780 DOI Author Url Publisher Url

Obaji SG, Cooper R, Somauroo J. 2012. Chiari network: a protective filter against pulmonary embolism in a case of polycythaemia. BMJ case reports, 2012 DOI Author Url Publisher Url

Cooper R, Obeyesekere M, Klein GJ, Modi S. 2012. Explain the A-V relationship PACE - Pacing and Clinical Electrophysiology, 35 :1389-1391 DOI Author Url Publisher Url

Somauroo JD, Cooper RM, Modi SS. 2012. Lessons learnt from a tragic loss British Journal of Cardiology, 19

Modi S, Barker D, Cooper R, Patwala A, Hall M. 2012. Pseudo SVT in the pacemaker patient PACE - Pacing and Clinical Electrophysiology, 35 DOI Author Url Publisher Url

Obaji SG, Cooper R, Somauroo J. 2012. Chiari network: A protective filter against pulmonary embolism in a case of polycythaemia BMJ Case Reports, DOI

Cooper RM, Magrath AF, Modi S, Somauroo JD. 2011. Angina without 'strangling and anxiety of the breast' CLINICAL MEDICINE, 11 :201-202 DOI Author Url Publisher Url

Cooper RM, Magrath AF, Modi S, Somauroo JD. 2011. Angina without 'strangling and anxiety of the breast' Clinical Medicine, Journal of the Royal College of Physicians of London, 11 :201-202 DOI Author Url

Cooper RM, White JDE, Magrath AF, Scott S, Finnerty J. 2010. Wegener's granulomatosis: a rare presentation EMERGENCY MEDICINE JOURNAL, 27 :890-890 DOI Author Url Publisher Url

Modi S, Cooper R, Hall M, Wright J, Todd D. 2010. Chest pain in pacemaker patients, the answer is not always antiplatelets and anticoagulants: A four-case series: Case report EMA - Emergency Medicine Australasia, 22 :347-350 DOI Author Url Publisher Url

Cooper RM, Krishnan U, Pyatt JR. 2010. Central venous spasm during pacemaker insertion Heart, 96 :1484 DOI Author Url Publisher Url

Cooper RM, Magrath AF, Somauroo JD. 2009. Pectus excavatum deforming right heart causing difficult right ventricular pacing Internet Journal of Cardiology, 6

Cooper RM, Morris JL. 2009. Thrombus extrusion through filter wire basket Catheterization and Cardiovascular Interventions, 74 :718 DOI Author Url Publisher Url

Cooper RM, Mandal AKJ, Finnerty J. 2008. Aspergillosis masquerading as frank haemoptysis Emergency Medicine Journal, 25 :739 DOI Author Url Publisher Url

Cooper RM, Hayat SA. 2008. Phlegmasia cerulea dolens, a rare complication of deep vein thrombosis Emergency Medicine Journal, 25 :334 DOI Author Url Publisher Url

Cooper ROBERT. Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review European Society for clinical investigation, DOI Author Url Publisher Url

Chapters

Verma A, Cooper R. 2023. Cardiology Sport and Exercise Medicine: An Essential Guide :145-161 DOI Publisher Url

Editorial/letter to the editor

Veselka J, Faber L, Liebregts M, Cooper R, Kashtanov M, Hansen PR, Bonaventura J, Polakova E, Hansvenclova E, Bundgaard H, ten Berg J, Jensen MK. 2021. Sex-Related Differences in Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy JACC: Cardiovascular Interventions, 14 :1390-1392 DOI Author Url Publisher Url

Conference publication

Ding WY, Meah M, Cooper R, Oxborough D, Somauroo J. 2017. DOES HYPERTROPHIC CARDIOMYOPATHY GENOTYPE AFFECT TISSUE DOPPLER IMAGING PARAMETERS OVER 3-YEAR FOLLOW-UP PERIOD? HEART, Annual Conference of the British-Cardiovascular-Society (BCS) 103 :A95-A96 DOI Author Url Publisher Url

Naraen A, McKay V, Ding WY, Rasoul D, Shaw M, Rao A, Wright D, Fairbairn T, Somauroo J, Stables R, Modi S, Mahida S, Todd D, Cooper R. 2017. YOUNGER AGE, POSITIVE FAMILY HISTORY AND REVERSE CURVE MORPHOLOGY PREDICT INFORMATIVE RESULTS FROM GENE PANEL ANALYSIS FOR HYPERTROPHIC CARDIOMYOPATHY (HCM) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC) 69 :835-835 DOI Author Url Publisher Url